Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-09-23
2008-09-23
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S146000, C548S190000, C548S193000, C548S194000, C548S195000
Reexamination Certificate
active
11202299
ABSTRACT:
The present invention relates to compounds of the formulawhich are useful in treating diseases characterized by the hyperactivity of MEK.Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
REFERENCES:
patent: 5770573 (1998-06-01), Arrhenius et al.
patent: 6583288 (2003-06-01), Goodnow et al.
patent: 6784298 (2004-08-01), Goodnow et al.
patent: WO 99/01426 (1999-01-01), None
patent: WO 01/83478 (2001-11-01), None
patent: WO 03/008365 (2003-01-01), None
J. M. English et al.,Trends in Pharm. Sci. 2002, 23(1), 40.
J. L. Bos,Cancer Res. 1989, 49, 4682.
A. Bonni et al,Science1999, 286, 1358.
H. Davies et al.Nature2002, 417, 949.
R. Herrera et al.Trends Mol. Med. 2002,8(4, Suppl.), S27.
C. F. Zheng et al.,J. Biol. Chem. 1993, 268, 11435.
S. Cowley et al.,Cell1994, 77, 841.
R. Seger et al.,J. Biol. Chem. 1992, 267, 14373.
Chu Xin-Jie
Fotouhi Nader
Huby Nicholas J. S.
Kong Norman
McDermott Lee Apostle
Hoffmann-La Roche Inc.
Johnston George W.
Rocha-Tramaloni Patricia S.
Shameem Golam M
LandOfFree
Substituted hydantoins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted hydantoins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted hydantoins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3904123